DelMar Pharmaceuticals Presents New VAL-083 Data at Two International Scientific Conferences November 7, 2016 • 8:30 AM EST
DelMar Pharmaceuticals Presents Overview of VAL-083's Unique Anticancer Mechanism at the European Association of Neuro-Oncology (EANO) Annual Meeting October 17, 2016 • 8:30 AM EDT
DelMar Pharmaceuticals Announces Upcoming Scientific Conference Presentations October 13, 2016 • 8:30 AM EDT
DelMar Pharmaceuticals Presents Data Supporting the Potential of VAL-083 as a New Treatment for Ovarian Cancer at the 11th Biennial Ovarian Cancer Research Symposium September 13, 2016 • 8:30 AM EDT
DelMar Pharmaceuticals and Accurexa to Collaborate in the Development of a Novel Combination Chemotherapy for the Local Treatment of Brain Cancer September 7, 2016 • 8:30 AM EDT
DelMar Pharmaceuticals to Present at the 18th Annual Rodman & Renshaw Global Investment Conference on September 13, 2016 August 30, 2016 • 8:30 AM EDT
DelMar Pharmaceuticals to Present at the 11th Biennial Ovarian Cancer Research Symposium August 11, 2016 • 8:30 AM EDT
DelMar Pharmaceuticals Announces Presentation at the European Association of Neuro-Oncology (EANO) Annual Meeting in October 2016 July 21, 2016 • 8:30 AM EDT
DelMar Pharmaceuticals to Ring the Nasdaq Stock Market Opening Bell on July 14 July 13, 2016 • 8:30 AM EDT